OTC Markets OTCPK - Delayed Quote USD

Pharmagreen Biotech Inc. (PHBI)

0.0012
+0.0001
+(9.09%)
As of 2:11:11 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Peter Wojcik B.A. President, CEO, Secretary, Treasurer & Director 93.96k -- 1972
Mr. Terry Kwan B.Com., C.A., CPA CFO & Principal Accounting Officer 93.96k -- 1948

Pharmagreen Biotech Inc.

2987 Blackbear Court
Coquitlam, BC V3E 3A2
Canada
702 803 9404 https://www.pharmagreen.ca
Sector: 
Healthcare

Description

Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.

Corporate Governance

Pharmagreen Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 11, 2025 at 10:59 AM UTC - August 15, 2025 at 12:00 PM UTC

Pharmagreen Biotech Inc. Earnings Date

Recent Events

August 14, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 19, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 18, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 12, 2023 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

February 14, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

January 17, 2023 at 12:00 AM UTC

10-K: Periodic Financial Reports

December 28, 2022 at 12:00 AM UTC

NT 10-K: Periodic Financial Reports

December 2, 2022 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 17, 2022 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 12, 2022 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.